All Outputs (2)

A description of pharmacists' interventions to optimise the treatment of adults with orally available Covid-drug, Paxlovid. (2024)
Presentation / Conference
STOIBER, A., GRAY, G., SAILER, G., HUF, W. and TONNA, A. 2024. A description of pharmacists' interventions to optimise the treatment of adults with orally available Covid-drug, Paxlovid. Poster presented at the 28th European Association of Hospital Pharmacists (EAHP) annual congress 2024 (EAHP 2024): sustainable healthcare; opportunities and strategies, 20-22 March 2024, Bordeaux, France.

Paxlovid ®, the only orally available COVID drug, consists of two main components: Nirmatrelvir and Ritonavir. Ritonavir is known for the potent inhibition of CYP (cytochrome P450) enzymes in the liver mainly of CYP3A4, resulting in a large number of... Read More about A description of pharmacists' interventions to optimise the treatment of adults with orally available Covid-drug, Paxlovid..

Bridging the theory-practice gap in pharmacy education using an authentic learning approach: a cross-sectional study. (2024)
Journal Article
DEPASQUALE, C. and GRAY, G. 2024. Bridging the theory-practice gap in pharmacy education using an authentic learning approach: a cross-sectional study. Pharmacy education [online], 24(1), pages 262-269. Available from: https://doi.org/10.46542/pe.2024.241.262269

Authentic learning environments highlight real-world relevance to students, contributing to readiness for practice. This study evaluated the impact of an educational activity on student pharmacist learning and personal/professional development. An ac... Read More about Bridging the theory-practice gap in pharmacy education using an authentic learning approach: a cross-sectional study..